Geoffroy Sommen

Global Pharmaceutical Manufacturing Executive

Talents

ParisMembre depuis 21 mai 2026

industrial transformationGMP manufacturing performanceDrug Substance Process Development & Lifecycle ManagementLate-Stage cGMP ManufacturingGlobal Technology Transfer (Sponsor & CDMO environments)FDA / ANSM / Global Regulatory InspectionsCMC Strategy & Regulatory Contribution & SubmissionsLarge-Scale Site Leadership (80–500 FTE)CDMO Oversight & Partnership DevelopmentLean Manufacturing & Continuous Improvement (Black Belt Certified)

Recruter cette personne

Envoyez une offre d'emploi directement à ce candidat

industrial transformationGMP manufacturing performanceDrug Substance Process Development & Lifecycle ManagementLate-Stage cGMP ManufacturingGlobal Technology Transfer (Sponsor & CDMO environments)

À propos

Senior pharmaceutical executive with over 20 years of experience across leading CDMOs and biotech organizations including Lonza, BASF, Siegfried, Novasep and DNA Script. Extensive expertise in Drug Substance development and GMP manufacturing across small molecules, peptides, HPAPI and DNA-based products. Proven track record in global site leadership (up to 500 employees), regulatory inspection readiness (FDA, ANSM and international agencies), and successful international technology transfers from development through commercialization.

Recognized for combining strong scientific depth with strategic operational leadership and Lean transformation capability

Expérience

General Manager, Interim Mission - SPI Pharma - France

(2025-07 - 2026-03)

Site & TechOps Director, Interim Mission - Provepharm - France

(2024-06 - 2025-06)

Site Director, Interim Mission - Novasep - France

(2020-10 - 2021-01)

Site Director, Head of Manufacturing Business Unit - Polypeptide - France

(2019-04 - 2020-08)

Full P&L responsibility for GMP manufacturing site with 500+ employees
Oversaw Drug Substance manufacturing across clinical and commercial stages
Led 3 successful FDA inspections and multiple international regulatory inspections (ANSM, NMPA, MFDS, Russian authorities, UN agencies) with no critical observations
Directed multiple international technology transfers, ensuring seamless scale-up and regulatory alignment
Managed senior leadership team (Directors & Department Heads) across MSAT, Quality, Production, Engineering and Supply Chain
Implemented Lean transformation program, improving operational efficiency and reducing deviations by 15-40%

Industrial Director, Interim Mission - Provepharm - France

(2022-12 - 2023-11)

Operations Director - Polypeptide - France

(2016-05 - 2019-04)

Industrial Director, Interim Mission - Provepharm - France

(2022-12 - 2023-11)

Industrial Group Director, Interim Mission - Axyntis - France

(2021-05 - 2021-11)

Head of API Plant - BASF Pharma - Evionnaz, Switzerland

(2013-09 - 2015-09)

Head of API Plant & Finishing - Siegfried - Evionnaz, Switzerland

(2015-09 - 2016-09)

Operational Excellence & Industrialization Group Leader - Lonza Braine SA - Belgium

(2009 - 2013)

Process Optimization Project Leader - Lonza Braine SA - Belgium

(2007 - 2009)

Postdoc - University of Zürich - Zürich, Switzerland

(2004 - 2005)

Postdoc - University of Florida - Gainesville, USA

(2003 - 2004)

Founder-Associate - Brasserie Saint Rémi - France

(2022-06 - present)

Full operational responsibility (regulatory compliance, HACCP, site permit, process optimization). Application of Lean methodologies to small-scale manufacturing.

Founder-Associate - Brasserie de la tabatière - France

(2021-11 - 2025-06)

Full operational responsibility (regulatory compliance, HACCP, site permit, process optimization). Application of Lean methodologies to small-scale manufacturing.